Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OPTIEMUS INFRACOM vs TRIMURTHI DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OPTIEMUS INFRACOM TRIMURTHI DRUGS OPTIEMUS INFRACOM/
TRIMURTHI DRUGS
 
P/E (TTM) x 45.0 -55.3 - View Chart
P/BV x 6.3 1.9 323.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 OPTIEMUS INFRACOM   TRIMURTHI DRUGS
EQUITY SHARE DATA
    OPTIEMUS INFRACOM
Mar-23
TRIMURTHI DRUGS
Mar-23
OPTIEMUS INFRACOM/
TRIMURTHI DRUGS
5-Yr Chart
Click to enlarge
High Rs43611 3,927.9%   
Low Rs1777 2,505.6%   
Sales per share (Unadj.) Rs136.71.7 7,882.1%  
Earnings per share (Unadj.) Rs4.9-0.1 -6,584.3%  
Cash flow per share (Unadj.) Rs6.40 -129,344.3%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs44.58.9 501.5%  
Shares outstanding (eoy) m85.868.10 1,060.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.25.2 42.8%   
Avg P/E ratio x62.9-122.7 -51.2%  
P/CF ratio (eoy) x48.0-1,963.5 -2.4%  
Price / Book Value ratio x6.91.0 672.8%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m26,33274 35,763.1%   
No. of employees `000NANA-   
Total wages/salary Rs m3992 24,626.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,73914 83,550.2%  
Other income Rs m5405 10,474.2%   
Total revenues Rs m12,27919 63,954.6%   
Gross profit Rs m179-5 -3,453.7%  
Depreciation Rs m1301 23,153.6%   
Interest Rs m580-   
Profit before tax Rs m531-1 -91,617.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1130 1,126,200.0%   
Profit after tax Rs m419-1 -69,793.3%  
Gross profit margin %1.5-36.8 -4.1%  
Effective tax rate %21.2-2.5 -847.8%   
Net profit margin %3.6-4.3 -83.6%  
BALANCE SHEET DATA
Current assets Rs m6,25342 14,738.3%   
Current liabilities Rs m4,6051 742,746.8%   
Net working cap to sales %14.0297.6 4.7%  
Current ratio x1.468.4 2.0%  
Inventory Days Days20721 2.8%  
Debtors Days Days1,15949,478 2.3%  
Net fixed assets Rs m2,78329 9,436.8%   
Share capital Rs m85981 1,060.0%   
"Free" reserves Rs m2,966-9 -32,774.0%   
Net worth Rs m3,82572 5,315.7%   
Long term debt Rs m1200-   
Total assets Rs m9,03672 12,564.5%  
Interest coverage x10.10-  
Debt to equity ratio x00-  
Sales to assets ratio x1.30.2 665.0%   
Return on assets %5.3-0.8 -636.5%  
Return on equity %10.9-0.8 -1,314.5%  
Return on capital %14.9-0.8 -1,847.7%  
Exports to sales %0.20-   
Imports to sales %1.00-   
Exports (fob) Rs m23NA-   
Imports (cif) Rs m118NA-   
Fx inflow Rs m230-   
Fx outflow Rs m1180-   
Net fx Rs m-940-   
CASH FLOW
From Operations Rs m121 1,218.9%  
From Investments Rs m-8211 -109,433.3%  
From Financial Activity Rs m699NA-  
Net Cashflow Rs m-1102 -6,472.4%  

Share Holding

Indian Promoters % 74.9 66.9 111.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 33.1 75.9%  
Shareholders   28,470 2,635 1,080.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OPTIEMUS INFRACOM With:   ADANI ENTERPRISES    MMTC    REDINGTON    SIRCA PAINTS INDIA    


More on AKANKSHA FIN vs TRIMURTHI DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AKANKSHA FIN vs TRIMURTHI DRUGS Share Price Performance

Period AKANKSHA FIN TRIMURTHI DRUGS S&P BSE TECK
1-Day 0.27% 0.00% -0.26%
1-Month 5.54% 0.00% -0.74%
1-Year 70.55% 85.64% 29.95%
3-Year CAGR 34.04% 41.71% 10.57%
5-Year CAGR 20.41% 19.68% 15.11%

* Compound Annual Growth Rate

Here are more details on the AKANKSHA FIN share price and the TRIMURTHI DRUGS share price.

Moving on to shareholding structures...

The promoters of AKANKSHA FIN hold a 74.9% stake in the company. In case of TRIMURTHI DRUGS the stake stands at 66.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AKANKSHA FIN and the shareholding pattern of TRIMURTHI DRUGS.

Finally, a word on dividends...

In the most recent financial year, AKANKSHA FIN paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 30.8%.

TRIMURTHI DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of AKANKSHA FIN, and the dividend history of TRIMURTHI DRUGS.

For a sector overview, read our telecom sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.